| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | SERES THERAPEUTICS INC | 246,645 | 7,311,000 | 0.07% | ||
| 102 | Redhill Biopharma Ltd | 564,900 | 7,293,000 | 0.07% | ||
| 103 | FLUIDIGM CORP DEL | 10,000,000 | 7,154,000 | 0.07% | PRN | |
| 104 | MACROGENICS INC | 317,000 | 6,790,000 | 0.07% | ||
| 105 | ADVAXIS INC COM NEW | 636,600 | 6,512,000 | 0.07% | ||
| 106 | SAGE THERAPEUTICS | 149,999 | 6,348,000 | 0.06% | ||
| 107 | ROKA BIOSCIENCE INC | 3,220,429 | 6,280,000 | 0.06% | ||
| 108 | Anacor Pharmaceuticals Inc | 53,300 | 6,274,000 | 0.06% | ||
| 109 | Lion Biotechnologies | 1,022,100 | 5,887,000 | 0.06% | ||
| 110 | IMMUNOMEDICS INC | 3,323,000 | 5,716,000 | 0.06% | ||
| 111 | HORIZON PHARMA PLC | 204,000 | 4,043,000 | 0.04% | ||
| 112 | INOTEK PHARMACEUTICALS CORP | 425,000 | 3,995,000 | 0.04% | ||
| 113 | VITAE PHARMACEUTICALS INC | 361,500 | 3,980,000 | 0.04% | ||
| 114 | Ascendis Pharma | 222,223 | 3,933,000 | 0.04% | ||
| 115 | FATE THERAPEUTICS INC COM | 692,900 | 3,693,000 | 0.04% | ||
| 116 | OREXIGEN THERAPEUTICS INC | 5,210,000 | 3,621,000 | 0.04% | PRN | |
| 117 | Biotie Therapies Corp. | 268,672 | 3,517,000 | 0.04% | ||
| 118 | PERNIX THERAPEUTICS HLDGS IN | 1,073,000 | 3,391,000 | 0.03% | ||
| 119 | ALIMERA SCIENCES INC | 1,500,000 | 3,315,000 | 0.03% | ||
| 120 | INVITAE CORP | 456,666 | 3,297,000 | 0.03% | ||
| 121 | OCULAR THERAPEUTIX INC | 208,900 | 2,937,000 | 0.03% | ||
| 122 | MEDIGUS LTD | 600,000 | 2,688,000 | 0.03% | ||
| 123 | ADAPTIMMUNE THERAPEUTICS PLC | 176,470 | 2,112,000 | 0.02% | ||
| 124 | BIOLINERX LTD | 1,038,600 | 1,589,000 | 0.02% | ||
| 125 | XTANT MED HLDGS INC | 475,439 | 1,550,000 | 0.02% | ||
| 126 | MANNKIND CORPORATION | 450,000 | 1,445,000 | 0.01% | Put | |
| 127 | QLT INC | 500,000 | 1,330,000 | 0.01% | ||
| 128 | Cogentix Medical Inc | 990,745 | 1,229,000 | 0.01% | ||
| 129 | AMARIN CORP PLC | 350,000 | 676,000 | 0.01% | ||
| 130 | BioMarin Pharmaceutical Inc | 500,000 | 653,000 | 0.01% | PRN | |
| 131 | BIOMARIN PHARMACEUTICAL INC | 500,000 | 653,000 | 0.01% | PRN | |
| 132 | ALIMERA SCIENCES INC | 200,000 | 442,000 | 0.00% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-15-001946, filed 2015.11.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
